Beta Blocker Recalled

Following reports of two antidepressant tablets found in a bottle of carvedilol, Zydus Pharmaceuticals Inc voluntarily recalled the entire lot, according to the August 25, 2021, US Food and Drug Administration (FDA) Enforcement Report.

The recall affects 500-count bottles of carvedilol tablets, 25 mg (NDC 68382-095-05), from lot Z006279 (Exp. 12/31/22). The affected tablets were manufactured by Cadila Healthcare Ltd., India, and distributed by Zydus Pharmaceuticals, Pennington, NJ, throughout the United States.

Zydus Pharmaceuticals initiated the recall August 13, 2021. On August 19, 2021, the FDA designated the recall Class II, signaling use of the product could cause temporary or medically reversible adverse health consequences. A remote possibility of serious harm also exists.

Carvedilol is a prescription medication used to treat high blood pressure and heart failure.